Date: Jun 17, 2013 Source: Streetinsider.com (
click here to go to the source)
Onconova Therapeutics, Inc. (Nasdaq: ONTX) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $75 million. The company plans to list on the Nasdaq Global Market under the ticker, "ONTX."
The offering is being made through Citigroup, Leerink Swann, Piper Jaffray, and Janney Montgomery Scott.
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer.